V-Bio Ventures logo

V-Bio Ventures

Crunchbase
Pitchbook
Crunchbase

Deals on record

4

Common Fundraising Type

Series A

Avidicure logo
Avidicure

Biotechnology • Multifunctional Antibodies

V-Bio Ventures logo
Kurma Partners logo
EQT Life Sciences logo
Curie Capital logo

Avidicure is a biotechnology company developing innovative multifunctional antibodies for oncology, focusing on non-small cell lung cancer.

Seed
$50M
04/24/2025
Article
Augustine Therapeutics logo
Augustine Therapeutics

Biotechnology • Therapies

VIB logo
V-Bio Ventures logo
PMV logo
Novo Holdings logo

Augustine Therapeutics is a biotechnology company developing therapies for neuromuscular, neurodegenerative, and cardio-metabolic diseases through selective inhibition of the HDAC6 enzyme.

Series A
$84.2M
03/24/2025
Article
ATB Therapeutics logo
ATB Therapeutics

Biologics • Therapeutic Antibodies

EQT Life Sciences logo
V-Bio logo
VIVES Partners logo
Wallonie Entreprendre logo

ATB Therapeutics is a biologics company developing therapeutic antibodies with novel cell-killing mechanisms for oncology and immunology therapies.

Series A
$57.1M
11/19/2024
Article
Corteria Pharmaceuticals logo
Corteria Pharmaceuticals

Biopharmaceuticals • Cardiovascular Therapies

OrbiMed logo
Jeito Capital logo
V-Bio Ventures logo
Omnes Capital logo

Corteria Pharmaceuticals is a biopharmaceutical company that develops first-in-class therapies for unaddressed heart failure subpopulations, with a focus on multi-organ benefits targeting the kidneys, heart, and vessels.

Series A
$69.6M
09/07/2023
Article